-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Pacira BioSciences, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2017 to 2023.
- Pacira BioSciences, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $3.46M.
- Pacira BioSciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $15.6M.
- Pacira BioSciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$7.95M, a 173% decline from 2021.
- Pacira BioSciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $10.9M.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)